- Our LinkedIn Page
- Our Twitter Feed
- Our Facebook Page
- Newsletter Subscribe to our e-newsletter. Current Issue
- Our Flickr Feed
- Our YouTube Feed
Tags
Global Health National Institutes of Health public policy STEM Education Food and Drug Administration drug development Research and Development health regulation NIH Health Care FDA vaccines biosimilars economy BIOTECH FDA approval healthcare BIO Investor Forum biotechnologyAuthors
- Abigail Hirsch
- Alan Eisenberg
- BIOtechNOW Editor
- Bruce Dale
- Celia Economides
- Colleen Lerro
- David Thomas, CFA
- George Goodno
- George MacDougall
- Jason Corum
- Jeff Joseph
- Jim Greenwood
- Karen Batra
- Kelly Cappio
- Lila Feisee
- Matt Carr
- Nathan Schock
- Paul Winters
- Paulina Ibarra
- Robbi Lycett
- Roy Zwahlen
- Sarah Sneeringer
- Sondra Behan
- Stephanie Fischer
- Stephen Marmaras
- Tracy Cooley
Category Archives: Health
Latest From Health
Get Active at the 2011 BIO International Convention
According to the American College of Sports Medicine, Washington, DC tops the ranks of the fittest cities in the nation. With the 2011 BIO International Convention quickly approaching, BIO hopes visitors will get active. From the BIO 5K Run/Walk to the BIO Golf Outing (both hosted by Novo Nordisk Inc) to the various outdoor activities right at our fingertips in the nation’s capital, attendees are encouraged to get outside and take advantage of all the Read More >
The Role of Intellectual Property in Global Health
BIO is committed to increased access to biologic medicines for patients throughout the world. As BIO President and CEO Jim Greenwood said last year when announcing our policy statement on Options for Increasing Access to Medicines in the Developing World, “We believe that the goals of increasing access to medicines, respecting intellectual property rights, and maintaining commercial viability are mutually supportive.” While there are frequent misguided calls to circumvent intellectual property (IP) rights in order Read More >
Applying A Holistic Approach to Solve a Complex Disease
By Dr. Timothy Coetzee, Chief Research Officer at the National MS Society Multiple sclerosis (MS) is a complex disease involving immune-system attacks on the central nervous system. Research into MS involves questions that dovetail many fields of science, including immunology, neuroscience, psychology and more. Promoting and funding collaborative research is one piece of the puzzle, receiving a great deal of media attention of late. However, it is even more important to apply a multi-faceted, rather Read More >
A Conversation with the Michael J. Fox Foundation for Parkinson’s Research
April is Parkinson’s Awareness Month so it seemed like a good opportunity to learn more about the Michael J. Fox Foundation for Parkinson’s Research. If you attended the 2007 BIO International Convention, you may have heard Michael J. Fox’s challenge to the audience to redeploy resources to advance promising therapies more quickly thru the drug development pipeline and his invitation to partner with the Foundation on those efforts. If you were not fortunate to be Read More >
FDA: A Cornerstone of America’s Economic Future
By Nancy Bradish Myers, JD, President, Alliance for a Stronger FDA For close to 20 years, we have been told that FDA oversees products that represent 25 percent of all consumer spending. This has always been an impressive statistic and often awakened Capitol Hill to the realization that FDA matters in important and unexpected ways. But is that all there is to FDA’s role in the U.S. economy? Fortunately it isn’t. FDA is a regulatory Read More >
